Roteas European Union - English - EMA (European Medicines Agency)

roteas

berlin-chemie ag - edoxaban tosilate - stroke; venous thromboembolism - antithrombotic agents - prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (nvaf) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (tia).treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults.

LIXIANA TABLET Canada - English - Health Canada

lixiana tablet

servier canada inc - edoxaban (edoxaban tosylate monohydrate) - tablet - 15mg - edoxaban (edoxaban tosylate monohydrate) 15mg - direct factor xa inhibitors

LIXIANA TABLET Canada - English - Health Canada

lixiana tablet

servier canada inc - edoxaban (edoxaban tosylate monohydrate) - tablet - 30mg - edoxaban (edoxaban tosylate monohydrate) 30mg - direct factor xa inhibitors

LIXIANA TABLET Canada - English - Health Canada

lixiana tablet

servier canada inc - edoxaban (edoxaban tosylate monohydrate) - tablet - 60mg - edoxaban (edoxaban tosylate monohydrate) 60mg - direct factor xa inhibitors